Cargando…

Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers

Tamsulosin, an alpha-1 adrenoreceptor antagonist, has been used as a primary option for medical treatment of benign prostate hyperplasia. An open-label, single-dose, randomized, three-treatment, three-period, three sequence crossover study was conducted to evaluate the pharmacokinetics (PKs) of 0.2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ban, Mu Seong, Kim, Yu Kyong, Kim, Byungwook, Jung, Jina, Kim, Yong-il, Oh, Jaeseong, Yu, Kyung-Sang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Clinical Pharmacology and Therapeutics 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781808/ https://www.ncbi.nlm.nih.gov/pubmed/33425801 http://dx.doi.org/10.12793/tcp.2020.28.e17

Ejemplares similares

Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients
por: Kim, Su Jin, et al.
Publicado: (2017)

Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia
por: Chung, Jae-Wook, et al.
Publicado: (2011)

The Authors Reply: Reply on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”
por: Kim, Su Jin, et al.
Publicado: (2017)

Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial
por: Shin, Yu Seob, et al.
Publicado: (2016)

Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
por: Fossler, Michael J., et al.
Publicado: (2015)

Letter to the Editor: Commentary on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”
por: Tae, Bum Sik, et al.
Publicado: (2017)

Efficacy of 0.4 mg tamsulosin monotherapy in patients with moderate-to-severe lower urinary tract symptoms
por: Kang, Tae Wook, et al.
Publicado: (2021)

An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin
por: Yang, Pei-Shan, et al.
Publicado: (2018)

Safety and pharmacokinetic comparison between fenofibric acid 135 mg capsule and 110 mg enteric-coated tablet in healthy volunteers
por: Seo, Yu-Bin, et al.
Publicado: (2023)

Beneficial Effect of Increasing the Dose of Tamsulosin to 0.4 mg in Japanese Patients with Benign Prostatic Hyperplasia
por: Hirose, Yasuhiko, et al.
Publicado: (2011)

The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers
por: Lockwood, Peter A., et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects
por: Kim, Hyun Chul, et al.
Publicado: (2023)

Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction
por: Ahn, Sun Tae, et al.
Publicado: (2020)

Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects
por: Swerdlow, Russell H., et al.
Publicado: (2016)

Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial
por: Sebastianelli, Arcangelo, et al.
Publicado: (2019)

A Prospective, Multicenter, Open-Label Study of Dose Escalation Therapy in Male Patients With Nocturia Refractory to 0.2-mg Tamsulosin Monotherapy
por: Yu, Ho Song, et al.
Publicado: (2019)

Is Tamsulosin 0.2 mg Effective and Safe as a First-Line Treatment Compared with Other Alpha Blockers?: A Meta-Analysis and a Moderator Focused Study
por: Shim, Sung Ryul, et al.
Publicado: (2016)

Efficacy of 4.0 mg versus 0.4 mg Folic Acid Supplementation on the Reproductive Outcomes: A Randomized Controlled Trial
por: Bortolus, Renata, et al.
Publicado: (2021)

Comparative pharmacokinetic and tolerability evaluation of two simvastatin 20 mg formulations in healthy Korean male volunteers
por: Moon, Seol Ju, et al.
Publicado: (2017)

Low-dose erythromycin in pediatrics: Formulation and stability of 20 mg hard gelatin capsules
por: Thevin, Patrick, et al.
Publicado: (2023)

Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions
por: Wu, Qingqing, et al.
Publicado: (2020)

Stabilization by Configurational Entropy of the Cu(II) Active Site during CO Oxidation on Mg(0.2)Co(0.2)Ni(0.2)Cu(0.2)Zn(0.2)O
por: Fracchia, Martina, et al.
Publicado: (2020)

Is configurational entropy the main stabilizing term in rock-salt Mg(0.2)Co(0.2)Ni(0.2)Cu(0.2)Zn(0.2)O high entropy oxide?
por: Fracchia, Martina, et al.
Publicado: (2022)

High-Entropy Sn(0.8)(Co(0.2)Mg(0.2)Mn(0.2)Ni(0.2)Zn(0.2))(2.2)O(4) Conversion-Alloying Anode Material for Li-Ion Cells: Altered Lithium Storage Mechanism, Activation of Mg, and Origins of the Improved Cycling Stability
por: Moździerz, Maciej, et al.
Publicado: (2022)

Development by Mechanochemistry of La(0.8)Sr(0.2)Ga(0.8)Mg(0.2)O(2.8) Electrolyte for SOFCs
por: Garcia-Garcia, Francisco J., et al.
Publicado: (2020)

A Supernova Search At Z = 0.2 - 0.4
por: Hardin, D
Publicado: (2000)

Influence of Solution Treatment Time on Precipitation Behavior and Mechanical Properties of Mg-2.0Nd-2.0Sm-0.4Zn-0.4Zr Alloy
por: Ma, Tao, et al.
Publicado: (2021)

2229. Relative Bioavailability of a Single Oral Dose of SUBA-Itraconazole 65 mg Capsule Compared with Conventional Itraconazole 100 mg Capsule Administered Under Fasted and Fed Conditions in Healthy Adult Volunteers
por: Mudge, Stuart, et al.
Publicado: (2019)

Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis
por: Nash, Peter, et al.
Publicado: (2016)

Pharmacokinetic comparison of two bazedoxifene acetate 20 mg tablet formulations in healthy Korean male volunteers
por: Yeun, Ji-Sun, et al.
Publicado: (2020)

Tunable pseudocapacitive contribution by dimension control in nanocrystalline-constructed (Mg(0.2)Co(0.2)Ni(0.2)Cu(0.2)Zn(0.2))O solid solutions to achieve superior lithium-storage properties
por: Chen, Hong, et al.
Publicado: (2019)

What is the optimal duration of the TILT after administration of 0.4 mg nitroglycerin spray?
por: Glockler, Antonia, et al.
Publicado: (2020)

Ocular Pharmacokinetics of a Novel Loteprednol Etabonate 0.4% Ophthalmic Formulation
por: Schopf, Lisa, et al.
Publicado: (2014)

Efficacy of cyclic and extended regimens of ethinylestradiol 0.02 mg ‐levonorgestrel 0.09 mg for dysmenorrhea: A placebo‐controlled, double‐blind, randomized trial
por: Harada, Tasuku, et al.
Publicado: (2021)

Modulating the Energy Band Structure of the Mg-Doped Sr(0.5)Pr(0.5)Fe(0.2)Mg(0.2)Ti(0.6)O(3−δ) Electrolyte with Boosted Ionic Conductivity and Electrochemical Performance for Solid Oxide Fuel Cells
por: Rauf, Sajid, et al.
Publicado: (2022)

Pharmacokinetics of DFN-15, a Novel Oral Solution of Celecoxib, Versus Celecoxib 400-mg Capsules: A Randomized Crossover Study in Fasting Healthy Volunteers
por: Pal, Arindam, et al.
Publicado: (2017)

Effect of Microstructure Refinement on the Corrosion Behavior of the Bioresorbable Mg-1Zn-0.2Ca and Mg-1Ca Alloys
por: Kulyasova, Olga B., et al.
Publicado: (2022)

Randomized Double-Blind Controlled Trial Comparing 0.2 mg, 0.1 mg, and No Intrathecal Morphine Combined With Periarticular Injection for Unilateral Total Knee Arthroplasty
por: Pathonsamit, Chompunoot, et al.
Publicado: (2020)

A new spinel high-entropy oxide (Mg(0.2)Ti(0.2)Zn(0.2)Cu(0.2)Fe(0.2))(3)O(4) with fast reaction kinetics and excellent stability as an anode material for lithium ion batteries
por: Chen, Hong, et al.
Publicado: (2020)

In vitro degradation, haemolysis and cytotoxicity study of Mg‐0.4Ce/ZnO(2) nanocomposites
por: Prabakaran, Meenachi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pfepe60ujrtn9pb9vrq99mouh3